Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

209.05
+0.10000.05%
Post-market: 209.800.7500+0.36%19:56 EDT
Volume:1.22M
Turnover:254.37M
Market Cap:10.53B
PE:33.12
High:209.84
Open:207.24
Low:206.01
Close:208.95
52wk High:217.12
52wk Low:138.79
Shares:50.35M
Float Shares:50.35M
Volume Ratio:0.90
T/O Rate:2.43%
Dividend:0.42
Dividend Rate:0.20%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.29
PE(LYR):-139.93

Loading ...

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
4 hours ago

Circio boosts circVec gene therapy data and secures funding runway to 2030

TIPRANKS
·
5 hours ago

iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit

Reuters
·
6 hours ago

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live
·
6 hours ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live
·
Yesterday

Political and General News Events from August 31

Reuters
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Yesterday

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Yesterday

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

TIPRANKS
·
Yesterday

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Yesterday

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Yesterday

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.
·
Aug 30

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

TIPRANKS
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Sector Update: Healthcare

MT Newswires Live
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29